Ledger.Open graph →
SEC Form D · filed December 6, 2022

InMed Pharmaceuticals Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Alexandra D. Mancini · Vancouver, British Columbia, CanadaExecEric C. Hsu · Vancouver, British Columbia, CanadaExecEric A. Adams · Vancouver, British Columbia, CanadaExec · DirectorBryan J. Baldasare · Vancouver, British Columbia, CanadaDirectorAndrew J. Hull · Vancouver, British Columbia, CanadaDirectorWilliam J. Garner · Vancouver, British Columbia, CanadaDirectorMichael C. Woudenberg · Vancouver, British Columbia, CanadaExecJanet J. Grove · Vancouver, British Columbia, CanadaDirectorYuridia V. Rodriguez · Grand Rapids, MIDirectorS. S. Singh · Bellevue, WAExec · DirectorJeff S. Drummond · Bellevue, WAExecUtpal S. Donde · Bellevue, WAExecPeter H. Diamandis, Md · Orlando, FLDirectorCraig M. Hurlbert · Hamilton, MTExecKenneth S. Cornick · Bellevue, WADirectorPaul Kirchgraber · Broomfield, CODirectorNicole J. Lemerond · Vancouver, British Columbia, CanadaDirectorSarah A. Li · Vancouver, British Columbia, CanadaExecCharles King · Murfreesboro, TNDirectorCharles Farguson · New York, NYExecRyan W. Howe · Cedar Falls, IAExec · DirectorAngela W. Strange · Cedar Falls, IADirectorRobert W. Smith, Jr · Cedar Falls, IAExecYosef A. Quint · Westwood, MAExecPetr G. Kilmo · Munsbach, LuxembourgDirectorMegan H. Pillsbury · Wilmington, DEDirectorNicole J. Lemerond · Vancouver, British Columbia, CanadaDirectorSarah A. Li · Vancouver, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗